W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

Transparency Council

Communication of the meeting of Transparency Council No. 48/2024 on 18 November 2024

more...

Position of the Transparency Council – Voxzogo (vosoritide)

more...

Position of the Transparency Council – Filsuvez (birch bark extract)

more...

Position of the Transparency Council – mexiletine

more...

Position of the Transparency Council – Elrexfio (elranatamab)

more...

Position of the Transparency Council – Shingrix

more...

Position of the Transparency Council – hypercholesterolemia

more...

Position of the Transparency Council – Luxturna (voretigene neparvovec)

more...

Communication of the meeting of Transparency Council No. 47/2024 on 12 November 2024

more...

The Transparency Council meeting 49/2024 on 25 November 2024

more...

Position of the Transparency Council – FruitiVits

more...

Position of the Transparency Council – Abrysvo respiratory syncytial virus vaccine (bivalent, recombinant)

more...

Position of the Transparency Council – Abrysvo respiratory syncytial virus vaccine (bivalent, recombinant)

more...

Position of the Transparency Council – Amvuttra (vutrisiran)

more...

The Transparency Council meeting 48/2024 on 18 November 2024

more...

Opinion of the Transparency Council – Prophylactic mastectomy

more...

Position of the Transparency Council – Trulicity (dulaglutide)

more...

Opinion of the Transparency Council – nivolumab

more...

Communication of the meeting of Transparency Council No. 45/2024 on 28 October 2024

more...

Opinion of the Transparency Council – Program of newborn screening in the Republic of Poland for 2019-2026

more...

Position of the Transparency Council – Kaftrio (ivacaftor + tezacaftor + elexacaftor)

more...

Position of the Transparency Council – Kalydeco (ivacaftor)

more...

Position of the Transparency Council – Nucala (mepolizumab)

more...

Position of the Transparency Council – Trodelvy (sacituzumab govitecan)

more...